Next Financial Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$280K Buy
3,049
+414
+16% +$49.5K 0.02% 758
2021
Q3
$334K Buy
2,635
+14
+0.5% +$2.04K 0.03% 622
2021
Q2
$436K Buy
2,621
+1,058
+68% +$171K 0.03% 525
2021
Q1
$284K Sell
1,563
-481
-24% -$112K 0.03% 645
2020
Q4
$409K Buy
2,044
+486
+31% +$98.8K 0.04% 450
2020
Q3
$341K Sell
1,558
-228
-13% -$48.3K 0.04% 462
2020
Q2
$341K Buy
1,786
+284
+19% +$49.8K 0.04% 379
2020
Q1
$233K Sell
1,502
-235
-14% -$27.3K 0.03% 488
2019
Q4
$145K Buy
1,737
+194
+13% +$14.8K 0.02% 810
2019
Q3
$104K Buy
1,543
+229
+17% +$15.1K 0.01% 896
2019
Q2
$87K Buy
1,314
+107
+9% +$6.24K 0.01% 963
2019
Q1
$67K Buy
+1,207
New +$73.7K 0.02% 652

Other funds holding TDOC

Next Financial Group's TDOC Position: Q4 2021 in Review

Next Financial Group increased its Teladoc Health (TDOC) stake by 16% in Q4 2021, buying an estimated $49.5K and bringing the position to 3,049 shares worth $280K. The position accounts for 0.02% of the portfolio, ranked #758.

Next Financial Group first reported a position in TDOC in Q1 2019 and has held it in 12 quarters since. The position peaked at $436K in Q2 2021. 728 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Next Financial Group held 3,049 shares of Teladoc Health worth $280K as of Q4 2021.
  • Next Financial Group bought 414 Teladoc Health shares in Q4 2021, an estimated $49.5K.
  • Teladoc Health made up 0.02% of Next Financial Group's portfolio in Q4 2021, its #758 holding.
  • Next Financial Group first reported a position in Teladoc Health in Q1 2019 and has held it in 12 quarters since.
  • Next Financial Group's Teladoc Health position peaked at $436K in Q2 2021.
  • 728 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.